|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/10 |
| (11) | Patento numeris | 3218397 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15797815.6 |
| Europos patento paraiškos padavimo data | 2015-11-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-09-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-02-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/060733 |
| Data | 2015-11-13 |
| (87) | Numeris | WO 2016/077789 |
| Data | 2016-05-19 |
| (30) | Numeris | Data | Šalis |
| 201462080094 P | 2014-11-14 | US | |
| 201462087087 P | 2014-12-03 | US |
| (72) |
CORTI, Davide, CH
LANZAVECCHIA, Antonio, CH
TREFRY, John, US
SULLIVAN, Nancy, US
MULANGU, Sabue, US
GRAHAM, Barney, US
MUYEMBE-TAMFUN, Jean-Jacques, CG
LEDGERWOOD, Julie, US
STANLEY, Daphne, US
|
| (73) |
Institute for Research in Biomedicine,
Via Vincenzo Vela 6, 6500 Bellinzona,
CH
Humabs Biomed S.A., Via Mirasole 1, 6500 Bellinzona, CH The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes of Health Office of Technology Transfer 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, MD 20852-7660, US The United States Government, as represented by The Secretary of The Army, 504 Scott Street, Fort Detrick, MD 21702, US |
| (54) | NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE |
| NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE |